Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Nifedipine GITS + Candesartan in Healthy Males
NCT03136666Phase 1Completed
- Sponsor
- Bayer
- Start
- Apr 2010
- Primary completion
- Jun 2010
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of nifedipine and candesartan cilexetil in hypertension (HTN), sponsored by Bayer. Primary endpoints: Overall summary of adverse events at 7 weeks, Safety related laboratory findings at 7 weeks and 4 more. Started Apr 2010; status: completed.
02
Drugs
nifedipinecandesartan cilexetil
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03136666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03136666.